Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 4
2005 4
2006 10
2007 5
2008 11
2009 8
2010 16
2011 16
2012 16
2013 13
2014 12
2015 20
2016 11
2017 17
2018 17
2019 31
2020 24
2021 19
2022 18
2023 14
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
EMAS position statement: Thyroid disease and menopause.
Mintziori G, Veneti S, Poppe K, Goulis DG, Armeni E, Erel CT, Fistonić I, Hillard T, Hirschberg AL, Meczekalski B, Mendoza N, Mueck AO, Simoncini T, Stute P, van Dijken D, Rees M, Duntas L, Lambrinoudaki I. Mintziori G, et al. Among authors: lambrinoudaki i. Maturitas. 2024 Apr 24;185:107991. doi: 10.1016/j.maturitas.2024.107991. Online ahead of print. Maturitas. 2024. PMID: 38658290
Postmenopausal women with higher TSH values within the normal range present improved handgrip strength: a pilot study.
Chatzivasileiou P, Armeni E, Chedraui P, Kontou L, Augoulea A, Palaiologou A, Kaparos G, Panoulis K, Alexandrou A, Vlachos N, Lambrinoudaki I. Chatzivasileiou P, et al. Among authors: lambrinoudaki i. Gynecol Endocrinol. 2024 Dec;40(1):2333432. doi: 10.1080/09513590.2024.2333432. Epub 2024 Apr 3. Gynecol Endocrinol. 2024. PMID: 38567465 Free article.
The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
Anagnostis P, Lallas K, Pappa A, Avgeris G, Beta K, Damakis D, Fountoukidou E, Zidrou M, Lambrinoudaki I, Goulis DG. Anagnostis P, et al. Among authors: lambrinoudaki i. Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075-8. Online ahead of print. Osteoporos Int. 2024. PMID: 38563960 Review.
Lower Urinary Tract Symptoms in Greek Women After Menopause: The LADY Study.
Lambrinoudaki I, Mili N, Augoulea A, Armeni E, Vakas P, Panoulis K, Vlahos N, Mikos T, Grimbizis G, Rodolakis A, Athanasiou S. Lambrinoudaki I, et al. Int Urogynecol J. 2024 Mar;35(3):627-636. doi: 10.1007/s00192-024-05724-4. Epub 2024 Jan 27. Int Urogynecol J. 2024. PMID: 38280043
EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA, Pofi R, Goulis DG, Isidori AM, Armeni E, Erel CT, Fistonić I, Hillard T, Hirschberg AL, Meczekalski B, Mendoza N, Mueck AO, Simoncini T, Stute P, van Dijken D, Rees M, Lambrinoudaki I. Kanakis GA, et al. Among authors: lambrinoudaki i. Maturitas. 2023 Dec;178:107854. doi: 10.1016/j.maturitas.2023.107854. Epub 2023 Oct 15. Maturitas. 2023. PMID: 37845136
Efficacy and safety of metformin during pregnancy: an update.
Paschou SA, Shalit A, Gerontiti E, Athanasiadou KI, Kalampokas T, Psaltopoulou T, Lambrinoudaki I, Anastasiou E, Wolffenbuttel BHR, Goulis DG. Paschou SA, et al. Among authors: lambrinoudaki i. Endocrine. 2024 Feb;83(2):259-269. doi: 10.1007/s12020-023-03550-0. Epub 2023 Oct 5. Endocrine. 2024. PMID: 37798604 Free PMC article. Review.
The severity of menopausal symptoms is associated with diabetes, and cardiometabolic risk factors in middle-aged women.
Armeni E, Kopanos S, Verykouki E, Augoulea A, Paschou SA, Rizos D, Kaparos G, Eleftheriadis M, Haidich AB, Goulis DG, Vlahos N, Lambrinoudaki I. Armeni E, et al. Among authors: lambrinoudaki i. Minerva Endocrinol (Torino). 2023 Sep 6. doi: 10.23736/S2724-6507.23.03905-2. Online ahead of print. Minerva Endocrinol (Torino). 2023. PMID: 37671810
238 results